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Abstract RB, p53 and p21Sdi1=WAF1=Cip1 interact in the induc-
tion of G1 arrest. We established osteosarcoma cell lines in which
a tetracycline-regulatable promoter controls the induction of RB,
p53 and p21. By using these cell lines, we investigated whether
RB, p53 or p21 regulates, in the same manner or differently,
expression and function of E2F-1 and its responsive genes. E2F-1
gene products and transcripts of the E2F-responsive genes
decreased in response to RB. Similar changes occurred to p53
and p21 when RB is present. However, in the absence of RB,
some of the E2F-responsive genes decreased in response to p53
but not to p21. Thus, RB is a critical component for regulating
the E2F-responsive genes, while p53 alone affects only a subset of
these genes. ß 2001 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
E2F-responsive elements are present in the promoters of
cell cycle-related genes, including E2F-1’s promoter [1^8]. Un-
phosphorylated RB protein binds to E2F-1 gene product
[9,10], inhibiting E2F-1 activity [11^13] and inducing G1 ar-
rest [14]. The level of unphosphorylated RB gene product is
thought to be critical for entering the G1 checkpoint [15^18].
On the other hand, the levels of E2F-1 mRNA and protein
£uctuate in the cell cycle [7,10] under complex modulation
mechanisms. Transcription of the E2F-1 gene is regulated
by E2F DNA-binding sites within its promoter region [7,8],
therefore, E2F-1 expression can also be repressed by RB
[19,20]. However, by binding E2F-1 gene product, RB also
protects E2F-1 protein from degradation [21,22]. Recently, it
has been demonstrated that p53 also binds to E2F-1 and in-
hibits E2F-1 transcriptional activity [23]. In addition, p21, a
cyclin-dependent protein kinase inhibitor and a potential me-
diator for p53-induced growth suppression [24,25], also inhib-
its the E2F activity in the cells either expressing or lacking
functional RB protein [26,27]. These ¢ndings suggest that
transcription of the E2F-1 gene can also be independently
repressed by p53 and p21. However, alterations of E2F-1
transcription and protein expression by RB, p53 and p21
have not been demonstrated.
Defects in the p53 and/or RB signaling pathways are fre-
quently detected in human cancer [28]. To assess the biolog-
ical signi¢cance of RB and p53 inactivation in osteosarcoma,
we previously established several osteosarcoma cell lines in
which the RB and p53 expressions were placed under tetracy-
cline (Tc) regulatory control [29]. Studies using these derived
cell lines demonstrated that RB induced di¡erentiation, p53
caused apoptosis, and either induced cell cycle arrest. The
results also indicated the presence of a pathway for p53-in-
duced cell cycle arrest independent of RB. However, it re-
mains unclear whether E2F-1 is an intermediate in the path-
way of p53-induced cell cycle arrest. To clarify the
mechanisms of E2F-1 regulation by p53 and RB, we analyzed
the e¡ects of RB, p53 and p21 expression on E2F-1 and E2F-
responsive genes, using a Tc-regulated inducible expression
system. Here, we demonstrate that the E2F-1 gene product
decreased in response to RB, but not to p53 or p21 in the
absence of RB, and that transcripts of the E2F-responsive
genes were decreased by RB, while only a subset of responsive
genes were reduced by p53 in the absence of RB.
2. Materials and methods
2.1. Plasmids and cDNA probes
Plasmids pTA-Hyg, pT2Xp53neo, pT2p21/neo and pT2p16neo
were constructed as described previously [29,30]. pUHD13-3, a Tc-
responsive trans-activator (tTA)-responsive luciferase reporter con-
struct [31], was provided by Dr. H. Bujard. E2F-1 cDNA probe
was provided by Dr. H. Matsushime. cDNA probes for B-MYB,
dihydrofolate reductase (DHFR), thymidylate synthase (TS) and glyc-
eraldehyde-3-phosphate dehydrogenase were generated by reverse
transcription-polymerase chain reaction.
2.2. Cell culture
The cells from human osteosarcoma cell lines Saos-2 and U-2 OS
(American Type Culture Collection, ATCC) were grown in Dulbec-
co’s modi¢ed Eagle’s medium (Nissui) supplemented with 10% fetal
calf serum at 37‡C in a humidi¢ed 5% CO2 atmosphere. Saos-2-de-
rived STA-e clone [29] was maintained in media containing 0.3 mg/ml
of hygromycin B (Calbiochem) and 1 Wg/ml of Tc (Sigma). Saos-2-
and U-2 OS-derived subclones described below were maintained in
media containing 0.5 mg/ml of G418 (Gibco BRL-Life Technologies),
0.3 mg/ml of hygromycin B and 1 Wg/ml of Tc.
2.3. Transfection
Saos-2-derived STA-e cells were transfected with pT2p21/neo using
lipofectamine reagent (Gibco BRL-Life Technologies) according to
the manufacturer’s protocol. Cells were grown in a medium contain-
ing hygromycin B, G418 and Tc, and were cloned and expanded for
further analyses.
U-2 OS cells were ¢rst transfected with pTA-Hyg. Cells grown in a
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medium containing hygromycin B were cloned and tested for expres-
sion of tTA by transient transfection of pUHD13-3 in the presence or
absence of 1 Wg/ml Tc and subsequent luciferase assay. A clone with
tTA expression was then transfected with pT2Xp53neo, pT2p21/neo
or pT2p16neo. Cells grown in a medium containing G418, hygrom-
ycin B and Tc were cloned and expanded for further analyses.
2.4. Western blot analysis
Cells were lysed with lysis bu¡er as described elsewhere [29]. 50 Wg
of cellular protein was separated in an 8% or 12.5% SDS^PAGE and
electroblotted to Hybond-ECL nitrocellulose membrane (Amersham).
Equal loading of protein was con¢rmed by staining the membrane
after detection. After blocking with 4% non-fat dry milk in Tris-bu¡-
ered saline, the membranes were incubated for 2 h with appropriate
antibodies (Abs). They were anti-p53 monoclonal Ab (mAb) PAb1801
(Oncogene Science), anti-RB mAb PMG3.245 (Pharmingen), anti-
E2F-1 mAb KH20 (a gift from Dr. J.A. Lees), anti-p21 Ab C-19
(Santa Cruz Biotechnology) and anti-p16 Ab (Pharmingen). The blots
were then probed on an ECL Western blotting detection system
(Amersham). The signal intensity was measured on an image scanner
(Agfa) with NIH Image (1.47) software or on a GS-525 Molecular
Imager system (Bio-Rad) using a chemiluminescent substrate Super-
Signal ULTRA (Pierce).
2.5. Northern blot analysis
Total RNA was isolated from the cells using a RNeasy1 Total
RNA Kit (Qiagen). 12 Wg of total RNA was electrophoresed and
transferred to nitrocellulose ¢lters. Equal loading of RNA was con-
¢rmed by comparing the intensities of stained bands for ribosomal
RNA. The ¢lters were hybridized with 32P-labeled cDNA probes and
exposed to Kodak XAR-5 or XLS-1 ¢lm at 380‡C. The signal inten-
sity was analyzed as described above.
2.6. Cell cycle analysis
The cells were cultured using growth media with or without fetal
calf serum for 24 h in the presence of 1 Wg/ml of Tc, and subjected for
the further culture with or without Tc for 12 or 24 h. At each time
point, cells were harvested. A part of the cells were stored for Western
and Northern blot analyses and the remaining cells were ¢xed with
70% ethanol. Cells were treated with 1 mg/ml of RNase A (Qiagen),
stained with 50 Wg/ml of propidium iodide (Molecular Probes), and
analyzed for cell cycle status by £ow cytometry using a £ow cytometer
(FACScan; Becton-Dickinson) and Cell Quest and ModFit software.
3. Results
3.1. E¡ect of RB on expression of E2F-1 and E2F-responsive
genes
To clarify the e¡ect of RB on E2F-1 mRNA and protein
levels, we utilized an osteosarcoma cell (Saos-2)-derived cell
line, SRB-1, in which RB expression is controlled by a Tc-
repressable promoter [29]. RB induction caused by removal of
Tc resulted in G1 arrest as described previously [29]. The
amounts of both E2F-1 mRNA and protein decreased mark-
edly at 24 and 48 h post RB induction (Fig. 1A,B). Since E2F-
1 protein induces the expression of the E2F-responsive genes
B-MYB, DHFR and TS [2^6], the e¡ect of RB induction on
E2F-1 activity can be measured by examining alterations in
these responsive gene expressions. Induction of RB biosynthe-
sis substantially reduced the expression of all of these E2F-
responsive genes at 24 and 48 h (Fig. 1B). It should be noted
that the decrease of E2F-1 and TS transcripts began at 12 h,
although the level of E2F-1 protein did not decrease at this
time. Thus, RB down-regulated E2F-1 activity, which was
accompanied by the reduction of E2F-1 protein levels.
3.2. E¡ect of p53 and p21 on expression of E2F-1 and
E2F-responsive genes in RB-retained cell lines
p53 and p21 could, in the presence of RB, down-regulate
E2F-1 bilaterally, since either might a¡ect E2F-1 through RB-
dependent or RB-independent pathways. To test this possibil-
ity, clones that expressed p53 and p21 under the control of the
Tc-regulatable promoter were derived from an osteosarcoma
cell line U-2 OS. In these clones wild-type RB and p53 genes
are expressed, but p16 gene is homozygously deleted [32^34].
Clones that express p16, also under the control of a Tc-regu-
latable promoter, were also established to examine a RB-de-
pendent pathway. The cells were arrested at G1 by induction
of each gene and were also arrested at G2/M by p53 and p21,
while apoptosis occurred only by p53 induction (data not
shown). Fig. 2 shows the results of Western and Northern
blot analyses of the clones, Up53-1, Up21-1 and Up16-2, at
48 h after induction of p53, p21 and p16, respectively. Upon
induction of p53 protein expression in Up53-1, endogenous
p21 protein was also induced, although its amount was less
than that of exogenously induced p21 in Up21-1 cells. In
Up16-2 cells, p16 protein was induced in a signi¢cant amount
by depletion of Tc, although it was also slightly detected in
the presence of Tc. With the induction of p53, Western blot
analysis of RB electrophoretic mobility demonstrated the ap-
pearance of more rapidly moving minor bands below the dif-
fuse major bands of RB, suggesting the appearance of hypo-
phosphorylated RB [15^18]. The induction of p21 or p16
Fig. 1. Time course of RB induction and expression of E2F-1 and
the E2F-responsive genes in Saos-2-derived SRB-1 cells analyzed by
Western blot (A) and Northern blot (B). Cells were harvested at 0,
12, 24 and 48 h after seeding with or without 1 Wg/ml of Tc. The
blots were probed with anti-RB or anti-E2F-1 mAbs (A), and with
E2F-1, B-MYB, DHFR, TS or glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) cDNA probes (B).
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resulted in a signi¢cant decrease in the major bands, and in-
crease in the intensity of more rapidly moving bands. In these
three clones, the induction of respective p53, p21 or p16 sub-
stantially decreased both E2F-1 mRNA and protein levels
(Fig. 2A,B), as well as expressions of the B-MYB, DHFR
and TS genes (Fig. 2B). Although down-regulation of E2F-1
activity by p53 was not as intense as that by p21 or p16, the
overall e¡ects of p53, p21 and p16 in U-2 OS-derived cells
were thus very similar to those of RB in Saos-2-derived SRB-1
cells.
3.3. E¡ect of p53 on expression of E2F-1 and E2F-responsive
genes in a RB-de¢cient cell line
To evaluate the possibility of a RB-independent pathway
mediated by p53 repression of E2F-1 activity, we analyzed
alterations in expression of E2F-1 and the E2F-responsive
genes in a Saos-2-derived subclone, Sp53-3, in which expres-
sion of p53 was placed under Tc regulatory control [29]. In
Sp53-3, apoptosis and G1 and G2/M arrest were induced by
p53 as described previously [29]. With p53 induction, the E2F-
1 protein level was slightly increased at 48 h after induction
(Fig. 3A), while its mRNA level showed a slight decrease at 24
and 48 h (Fig. 3B). On the other hand, expression of the B-
MYB and DHFR genes decreased signi¢cantly at 24 and 48 h,
similar to the case of RB induction. However, TS gene ex-
pression did not decrease (Fig. 3B). Thus, in the absence of
RB, p53 repressed only a subset of E2F-responsive genes
without reducing E2F-1 protein levels.
3.4. E¡ect of p21 on expression of E2F-1 and E2F-responsive
genes in RB-de¢cient cell lines
To investigate whether p21 is a mediator of p53 for repres-
sion of E2F-1 activity, we established Saos-2-derived sub-
clones, Sp21-2, Sp21-5 and Sp21-7, in which expression of
p21 was under Tc regulatory control (Fig. 4). Sp21-N was
Fig. 2. Western blot analysis of p53, p21, p16, RB and E2F-1 (A) and Northern blot analysis of E2F-1, B-MYB, DHFR, TS and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) (B) in U-2 OS-derived subclones. Up53-1, Up21-1 and Up16-2 are subclones that express p53, p21
and p16, respectively, under the control of a Tc-regulatable promoter. UTA-neo is a control clone, which was isolated following transfection of
pT2p21/neo and negative for exogenous p21. Samples in control lanes were small cell lung cancer cell line Lu135 in p53 [29] and E2F-1, p21-in-
duced Sp21-2 cells in p21, Saos-2 cells in p16, and lung adenocarcinoma cell line A427 in RB [29]. Cells were harvested at 48 h after seeding
with or without 1 Wg/ml of Tc. The blots were probed with Abs against p53, p21, p16, RB or E2F-1 (A), and with cDNA probes (B).
Fig. 3. Time course of p53 induction and expression of E2F-1 and
the E2F-responsive genes in Saos-2-derived Sp53-3 cells analyzed by
Western blotting (A) and Northern blotting (B). Cells were har-
vested at 0, 12, 24 and 48 h after seeding with or without 1 Wg/ml
of Tc. The blots were probed with anti-p53 or anti-E2F-1 mAbs
(A), and with the indicated cDNA probes (B).
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made as a negative control for p21 induction. Induction of
p21 in these cells was examined using the clone Sp53-3, which
also induces p21, as a positive control. At 48 h after seeding
without Tc, signi¢cant amounts of p21 proteins were detected
in the p21-inducible clones as in the case of the clone Sp53-3
(Fig. 4A). These subclones showed G1 and G2/M arrest as a
result of p21 induction (data not shown). However, p21 in-
duction signi¢cantly increased the E2F-1 protein levels in
these clones (Fig. 4A). In the time course experiment with
Sp21-2, the induced p21 protein level reached a maximum
at 12 h post induction and remained at this level for up to
48 h (Fig. 4B). This was accompanied by a gradual increase in
E2F-1 protein levels that reached 5.0 times at 48 h (Fig. 4B),
although its mRNA level was up by only 30% even at earlier
time points (Fig. 4C). p21 induction also increased transcripts
of B-MYB and DHFR at 24 and 48 h (Fig. 4C). Thus, p21
alone was unable to repress the activity of E2F-1, directly or
indirectly, in Saos-2 cells.
3.5. Alterations in the expression level of E2F-1 and
E2F-responsive genes by RB and p53 expression in a
serum-starved state
Some of the changes in E2F-1 and E2F-responsive genes
could be the result of more indirect e¡ects of the general cell
cycle alteration. In order to rule out the possible role of in-
direct e¡ects, we evaluated the e¡ects of RB and p53 induc-
tion in SRB-1 and Sp53-3 cells, respectively, in a serum-
starved state, in which the alterations in the expression of
induced cell cycle genes were minimized (Table 1). By the
serum depletion, the E2F-1 protein levels decreased in both
clones, but were not further altered by RB or p53 induction
(Fig. 5A). Serum starvation also resulted in the decrease of
Fig. 4. Western blot analysis of p21 and E2F-1 proteins (A,B) and Northern blot analysis of the E2F-1 and E2F-responsive gene mRNAs (C)
in Saos-2-derived subclones, in which p21 expression is controlled by a Tc-regulatable promoter. Cells were harvested at 48 h (A), and at 0, 12,
24 and 48 h (B,C; Sp21-2 was used) after seeding with or without 1 Wg/ml of Tc. The blots were probed with Abs against p21 or E2F-1 (A,B),
and with the cDNA probes (C).
Table 1
E¡ect of RB and p53 expression on the cell cycle distribution in Saos-2-derived clones in a serum-starved state
Clone Serum Tc Time after induction (h) Cell cycle distribution (%)
G0/G1 S G2/M
SRB-1 + + 0 49.2 þ 3.5 36.3 þ 2.5 14.6 þ 1.1
+ 3 12 54.3 þ 2.3 20.5 þ 2.0 25.3 þ 0.3
+ + 12 46.7 þ 0.5 29.6 þ 1.1 23.7 þ 0.6
Sp53-3 + + 0 42.2 þ 1.5 39.7 þ 0.3 18.2 þ 1.9
+ 3 24 51.1 þ 1.7 19.8 þ 0.2 29.2 þ 1.5
+ + 24 51.7 þ 2.1 29.3 þ 1.6 19.0 þ 0.5
SRB-1 3 + 0 75.3 þ 2.7 6.8 þ 1.5 18.1 þ 1.3
3 3 12 85.1 þ 1.6 4.9 þ 0.2 10.1 þ 1.5
3 + 12 84.6 þ 1.6 5.1 þ 0.2 10.4 þ 1.7
Sp53-3 3 + 0 73.1 þ 0.8 9.9 þ 0.5 17.1 þ 0.2
3 3 24 71.4 þ 2.6 13.1 þ 1.1 15.6 þ 1.6
3 + 24 70.9 þ 2.6 15.8 þ 1.6 13.4 þ 0.9
Each value is expressed as the mean þ S.D. of three independent experiments.
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E2F-1, B-MYB, DHFR and TS gene expressions. However,
induction of RB in SRB-1 further decreased E2F-1 and TS
gene expressions (Fig. 5B). On the other hand, p53 induction
further reduced B-MYB and DHFR gene expressions in Sp53-
3 cells (Fig. 5B). These e¡ects of RB and p53 were not ac-
companied by cell cycle alterations (Table 1), but identical
with the case of non-starved cells (Figs. 1B and 3B). There-
fore, it was suggested that the e¡ects on E2F-1 and TS gene
expression by RB and those on the B-MYB and DHFR genes
by p53 were not only the result of alterations in the cell cycle.
4. Discussion
To clarify the e¡ects of p53 and RB on expression and
transcriptional function of E2F-1, we investigated the e¡ect
of induced RB, p53 and p21 expression on the expression of
E2F-1 and the E2F-responsive genes using a Tc-regulated in-
ducible expression system. In the presence of RB, expression
of E2F-1 and the E2F-responsive genes decreased either by
p53 or by p21, in a similar pattern with induced RB expres-
sion. This result supports the concept that RB is a critical
component for regulation of E2F-1 in the p53-p21 signaling
pathway for induction of G1 arrest. However, in the absence
of RB, E2F-1 gene product did not decrease with induction of
p53 expression, although G1 arrest accompanied by B-MYB
and DHFR repression was observed. This result indicates the
existence of another pathway for p53 to induce G1 arrest in
addition to the p21-RB-mediated pathway. p21 is improbably
a component of such a pathway, since p21 did not have an
e¡ect to repress B-MYB and DHFR expression without RB.
It is possible that other RB family proteins, as well as other
E2F family proteins, are involved in such a pathway, and
identi¢cation of these regulatory genes is important, because
such genes should also play an important role in cell cycle
regulation in cancer cells. For this purpose, we are extending
our search for genes regulated by the p53 gene using the in-
ducible approach demonstrated in this study.
Expression of E2F-1 itself was reduced by RB, which was
accompanied by reduced expression of other E2F-1-responsive
genes. The time course experiment showed that E2F-1 and TS
transcripts decreased at 12 h after depletion of Tc without
reduction of the E2F-1 protein. This would be explained by
repression of E2F-1 activity due to RB binding to E2F-1
[12,13]. On the other hand, expression of the B-MYB and
DHFR genes was not signi¢cantly a¡ected at 12 h post in-
duction. The decrease in B-MYB and DHFR expression only
occurred later and was accompanied by reduction of the E2F-
1 protein level. Thus, the level of E2F-1 protein expression is
also an important factor for regulation of the E2F-responsive
genes in addition to its RB binding function. Down-regulation
of E2F-1 protein amount by RB has not been demonstrated
[35,36]. Therefore, such a reduction should be taken into ac-
count when interaction of RB with E2F-1 is considered.
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